DocDollars

Modernatx, Inc.

MA · United States · Reporting entity ID 100000961851

Total reported 2019–2025
$2.68B
#8 of 2,960 reporting companies — 3.2% of all reported industry payments
$11.6M in general payments across 6,047 records, plus $2.67B in research funding across 732,462 records.

How it breaks down

General payments $11,630,272
Research funding $2,669,180,034

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Modernatx, Inc. reported $2.68B to US doctors and teaching hospitals from 2019 to 2025, ranking #8 of 2,960 reporting companies. 100% of that was research funding and 0% general payments such as consulting, speaking, food and travel. 6,047 general payment records and 732,462 research records were filed.

Common questions about Modernatx, Inc.

How much has Modernatx, Inc. paid US doctors?

Modernatx, Inc. reported $2,680,810,306 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $11,630,272 in general payments, $2,669,180,034 in research funding.

How does Modernatx, Inc. rank among drug and device companies?

It ranks #8 of 2,960 reporting entities by total reported value, about 3.2% of all industry payments in the dataset.

Does a payment from Modernatx, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.